Syneos Well being eyes sale of firm as contract backlog shrinks – Reuters Information Company

OffersWell being

Shares of Syneos Well being Inc rose 13% after Reuters solely reported that the corporate is making a brand new effort to promote itself. The trouble comes within the wake of a decreased backlog of contracts for offering scientific analysis to drug builders that led to a plunge within the worth of its shares over the previous yr. Syneos has employed Financial institution of America Corp and Centerview Companions LLC for monetary recommendation because it embarks on a brand new spherical of talks with potential acquirers that will embrace business friends and personal fairness companies. 

Market Influence

Syneos shares rose 13% on the information in morning commerce to $43.35 a share on the time of reporting.

Article Tags

Subjects of Curiosity: OffersWell being

Sort: Reuters Finest

Sectors: Enterprise & FinancePrescribed drugs & Healthcare

Areas: Americas

International locations: United States

Win Varieties: Exclusivity

Story Varieties: Unique / Scoop

Media Varieties: Textual content

Buyer Influence: Vital Nationwide Story

Supply hyperlink

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
Leave A Reply

Your email address will not be published.